Clinical Safety of Expanded Hemodialysis Compared with Hemodialysis Using High-Flux Dialyzer during a Three-Year Cohort

• Published in: Journal of clinical medicine 2022-04, Vol.11 (8), p.2261
• Main Authors: Cho, Nam-Jun, Jeong, Seung-Hyun, Lee, Ka Young, Yu, Jin Young, Park, Samel, Lee, Eun Young, Gil, Hyo-Wook
• Format: Article
• Language: English
• Subjects: Clinical medicine; Cytokines; Dialysate; Dialyzers; Hemodialysis; Inflammation; Laboratories; Membranes; Patients; Survival analysis; Tumor necrosis factor-TNF; Values
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm11082261

Expanded hemodialysis (HD) equipped with a medium cut-off (MCO) membrane provides superior removal of larger middle molecules. However, there is still little research on the long-term benefits of expanded HD. Over a three-year period, this observational study evaluated the efficacy and safety profile of expanded HD for inflammatory cytokines, including IL-6. We conducted a prospective cohort study to investigate the inflammatory cytokine changes and a retrospective observational cohort study to investigate long-term clinical efficacy and safety over a three-year period. We categorized the patients according to dialyzer used: MCO and high-flux (HF) dialyzer. The inflammatory cytokines, including IFN-γ, IL-1β, IL-6, and TNF-α, were measured annually. The concentrations and changes of the four cytokines over time did not differ between the HF group ( = 15) and MCO group ( = 27). In both prospective and retrospective (HF group, = 38; MCO group, = 76) cohorts, there were no significant differences in either death, cardiovascular events, infections, or hospitalizations. Furthermore, the temporal changes in laboratory values, including serum albumin and erythropoietin prescriptions, did not differ significantly between the two groups in either the prospective or retrospective cohorts. In conclusion, clinical efficacy and safety outcomes, as well as inflammatory cytokines, did not differ with expanded HD compared with HF dialysis during a three-year treatment course, although the level of inflammatory cytokine was stable.